Skip to main content
PFSA
NASDAQ Life Sciences

Profusa Clears Key Hurdle for G3 Deal, Discloses $108M Target Revenue

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.716
Mkt Cap
$333.106K
52W Low
$0.51
52W High
$1,593.754
52W Position info
40% above low
Off High info
100% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

PFSA sits 40% above its 52-week low of $0.51 on light trading volume (0.2× avg).

Summary

Profusa says it has received G3 Vision Labs' PCAOB-audited FY2024 and FY2025 financials plus reviewed first-half 2026 statements — a core condition to exercising its option to acquire G3. The disclosure puts real numbers on the target for the first time: G3 generated $108 million of FY2025 revenue and $5.0 million of adjusted EBITDA, though it posted a $2.4 million net loss. Profusa has also exchanged $10.7 million of debt and liabilities into a new non-voting convertible preferred series and borrowed $0.7 million in October under its Ascent Partners note to fund near-term working capital. CEO Jack Stover said he believes the company is on track to close by year-end. The scale gap is stark — a micro-cap shell absorbing a nine-figure-revenue lab business — and the preferred converts into common only after stockholder approval, so dilution and the shareholder vote are the gating items. Watch for the stockholder approval and option exercise; Stover targets closing by end of 2026.

At the time of this announcement, PFSA was trading at $0.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $333.1K. The 52-week trading range was $0.51 to $1,593.75. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Nov 10, 2026, 5:09 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.5203
Real-time Price: $0.490 info
Change: -$0.0303 (-6%) info
Market Cap: $333.106K info
PFSA
Nov 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.530
Real-time Price: $0.490 info
Change: -$0.040 (-8%) info
Market Cap: $333.106K info
PFSA
Oct 15, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.26
Real-time Price: $0.490 info
Change: -$0.770 (-61%) info
Market Cap: $333.106K info
PFSA
Oct 09, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $0.490 info
Change: -$0.920 (-65%) info
Market Cap: $333.106K info
PFSA
Oct 05, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.74
Real-time Price: $0.490 info
Change: -$1.25 (-72%) info
Market Cap: $333.106K info